Overview

Pharmacotherapy and Intensive Treatment - 2

Status:
Completed

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Phase:

Phase 4

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborator:

VA Office of Research and Development

Treatments:

Carbamazepine